Journal
AMERICAN JOURNAL OF MEDICAL GENETICS
Volume 115, Issue 3, Pages 183-188Publisher
WILEY-LISS
DOI: 10.1002/ajmg.10692
Keywords
lung cancer; cytogenetic imbalances; genetic/epigenetic changes; tumor suppressor genes; oncogenes; molecular biomarkers
Categories
Funding
- NCI NIH HHS [CA-06927, CA-58184] Funding Source: Medline
Ask authors/readers for more resources
The development and progression of lung cancer is a multistep process characterized by the accumulation of numerous genetic and epigenetic alterations, some of which occur early in the course of disease. In this review, we summarize cytogenetic imbalances and molecular genetic/epigenetic changes seen in human small-cell and non-smallcell lung cancer. Alterations of tumor suppressor genes and oncogenes leading to perturbations of key cell-regulatory and growth-control pathways are highlighted. The translational implications of molecular biomarkers for risk assessment, early detection, and monitoring of chemoprevention trials are discussed. (C) 2002 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available